Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 18, 2008 09:01 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Updates Glufosfamide Clinical Development Program

REDWOOD CITY, Calif., Jan. 18, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today provided guidance on the clinical development of glufosfamide and announced results from a...